Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

1. BMY has a dividend yield of 5.15%, attracting income-focused investors. 2. Analysts maintain mixed ratings, impacting investor sentiment and price targets. 3. FDA granted Breakthrough Therapy Designation for a drug targeting lung cancer. 4. Citigroup cut BMY's price target from $51 to $47 earlier this month. 5. Morgan Stanley rated BMY as Underweight, lowering the price target from $36 to $34.